Researchers explore present and future treatment options for hepatocellular carcinoma using immunotherapy retrieved 22 May 2024 from https://medicalxpress.com/news/2024-05-explore-future-treatment-options-hepatocellular.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.2 hours agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Combined therapy makes headway for liver cancerA drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two clinical trial conducted by UT Southwestern Medical Center.
Source: medical_xpress - 🏆 101. / 51 Read more »
Study reveals how gender affects liver transplant success in cancer patientsLiver transplantation is a life-saving option for those with hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. Although often successful, outcomes can vary widely among recipients.
Source: medical_xpress - 🏆 101. / 51 Read more »
Liver cancer: Molecular signaling pathway of tumor development decodedAs a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain limited, the incidence is increasing.
Source: medical_xpress - 🏆 101. / 51 Read more »
Study finds targeting BET and OXPHOS causes synthetic lethality in liver cancerPrimary hepatocellular carcinoma (HCC), the major type of liver cancer, is a leading cause of worldwide cancer-related death. End-stage liver cancer patients have limited treatment options due to the lack of druggable targets, and the treatment outcome is usually complicated by the heterogeneous tumor microenvironment.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers develop genetic test for early detection of high cardiovascular riskClonal hematopoiesis is a phenomenon caused by mutations in hematopoietic stem cells and can lead to blood cancer. We now know that it occurs also in people with normal blood counts, where it is associated with an increased risk of life-threatening atherosclerotic cardiovascular disease.
Source: medical_xpress - 🏆 101. / 51 Read more »